|1.||Ge, Yigong: 2 articles (08/2010 - 07/2010)|
|2.||Fernández-Olmos, A: 1 article (09/2010)|
|3.||Juan, C: 1 article (09/2010)|
|4.||Zamorano, L: 1 article (09/2010)|
|5.||Cantón, R: 1 article (09/2010)|
|6.||Ge, Y: 1 article (09/2010)|
|7.||Oliver, A: 1 article (09/2010)|
|8.||Talbot, George H: 1 article (08/2010)|
|9.||Whitehouse, M J: 1 article (08/2010)|
|10.||Friedland, Ian: 1 article (08/2010)|
09/01/2010 - "Therefore, CXA-101 is envisaged as a valuable alternative for the treatment of chronic respiratory infection caused by P. "
07/01/2010 - "Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1."
|2.||Gram-Negative Bacterial Infections
09/01/2008 - "Introduction of various amino groups to the 4-position of a 3-amino-2-methylpyrazole cephalosporin 3-side chain resulted in enhanced MIC values against multiple Pseudomonas aeruginosa strains and ultimately led to the discovery of FR264205 (15) with excellent anti-bacterial activity and weak convulsion effect by direct intracerebroventricular injection assay."
|4.||Cystic Fibrosis (Mucoviscidosis)
|5.||Bacterial Infections (Bacterial Infection)
|2.||Cephalosporins (Cephalosporin Antibiotics)
|3.||Anti-Bacterial Agents (Antibiotics)